Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2026-03-01 @ 4:46 PM
Study NCT ID:
NCT06082934
Status:
RECRUITING
Last Update Posted:
2023-10-13
First Post:
2023-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Sponsor:
Organization: